PPT-  Opioid-sparing clinical trial objectives and outcomes: chronic pain

Nathaniel Katz MD MS Associate Professor of Anesthesia Tufts University CEO Analgesic Solutions IMMPACTXXI July 2627 2018 Washington DC Scenarios Hypotheses Nonopioid analgesic. Daniel Ford, PharmD, BCPS, BCCCP. Pharmacy Clinical Practice Manager. Pharmacy Residency Program Director. NorthBay Healthcare. ?. Itinerary. Stereotypes. Weekend Warrior. Long standing arthritic. “My . Annie Ottney, . PharmD. , BCPS. Learning Objective. Identify non-opioid medications that can be used in the management of chronic pain. Opioid Epidemic . Concurrent use of opioids and benzodiazepines across United States is HIGH. MPhA. MTM Fall Symposium. Kathryn Perrotta, . PharmD. , MBA, BCPS. November 16, 2012. Disclosure Statement. Define the health economic impact of the use of . opioid. analgesics in the treatment of pain . Kenneth L. Kirsh. , . Ph.D.. Clinical Research Educator and Research Scientist. Millennium . Laboratories. Millennium Research Institute. San Diego, CA. The Opioid Pendulum. Opiophobia. Balance of Addiction Medicine and Pain Management Principles. The Role of Opioid Medication in Chronic Pain Management Lorraine Widdall, MS APRN BC Interventional Spine and Pain Center Effective December 15, 2013 Emergency rule that temporarily adds provisions under P.L. 185-2013 (SEA246) regarding physicians prescribing opioids for chronic pain. Department of Psychiatry and Behavioral Sciences Johns Hopkins University School of Medicine 1 What is the Evidence for an Opioid-Sparing Effect of Cannabis? Assistant Professor Patrick H. Finan, Ph.D Appropriate Opioid Medication Use as Part of a Comprehensive Pain Management Approach MPhA MTM Fall Symposium Kathryn Perrotta, PharmD , MBA, BCPS November 16, 2012 Disclosure Statement Define the health economic impact of the use of Attacking Pain on all Fronts Edward C. Covington, M.D. Why a Symposium on Pain? It’s difficult Many treatments, none fully effective Patients suffer unnecessarily Optimal treatment requires A combination of interventions Dean Drosnes, MD, FASAM. Associate Medical Director. Director, Chronic Pain Treatment Program. Caron Treatment Centers. Disclosures. Name. Commercial Interests. Relevant Financial Relationships: What Was Received. Daniel P. Edney MD FACP. Objectives. Review common complications. Review CDC treatment guidelines. Review basic exit strategies. Common Complications. Tolerance. Dependency. Opioid Induced Hyperalgesia. Richard W. Rosenquist, M.D.. Chairman, Pain Management Department. Cleveland Clinic. Cleveland, OH. Disclosure. Royalties: . UpToDate. Royalties: Oxford Medical Press. Consultant: Mainstay Medical. Feedback from the Oxford Advanced Pain and Symptom Management Course –July 18. Anne Hounsell, Speciality Doctor, The Rowans Hospice. 6/12/18. Objectives. The use of opioids in CNCP-risks and benefits.. . Pain. An . Educational . Slide. . Set. American Society of Hematology . 2020 Guidelines . for . Management of . Venous . Thromboembolism. Slide . set. . authors:. Ahmar . U. . Zaidi, . MD, . Children’s . Research . designs, methods, and study execution . Michael C. Rowbotham, MD. Chief Research Officer, Sutter Health. Adjunct Professor, UCSF Anesthesia. Professor Emeritus, UCSF Neurology. What does ‘opioid sparing’ mean and what are the...